Billiontoone, Inc. (NASDAQ:BLLN) Receives Average Recommendation of “Moderate Buy” from Analysts

Billiontoone, Inc. (NASDAQ:BLLN) has earned an average rating of “Moderate Buy” from the ten research firms that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and six have assigned a buy recommendation to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $125.2857.

A number of equities analysts recently commented on BLLN shares. Wells Fargo & Company dropped their price objective on Billiontoone from $110.00 to $90.00 and set an “equal weight” rating on the stock in a report on Thursday, March 5th. Guggenheim increased their price target on Billiontoone from $100.00 to $120.00 and gave the company a “buy” rating in a report on Wednesday, May 13th. BTIG Research lowered their price target on Billiontoone from $140.00 to $130.00 and set a “buy” rating on the stock in a report on Thursday, May 7th. Wall Street Zen upgraded Billiontoone from a “hold” rating to a “buy” rating in a report on Saturday, March 7th. Finally, Weiss Ratings downgraded Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a report on Friday, June 5th.

Insider Activity at Billiontoone

In other Billiontoone news, insider Bosch John Roderick Ten sold 2,832 shares of the stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $101.47, for a total transaction of $287,363.04. Following the transaction, the insider owned 34,968 shares in the company, valued at $3,548,202.96. This trade represents a 7.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Oguzhan Atay sold 26,250 shares of the stock in a transaction that occurred on Monday, June 8th. The shares were sold at an average price of $97.66, for a total value of $2,563,575.00. Following the transaction, the insider owned 20,000 shares in the company, valued at approximately $1,953,200. This trade represents a 56.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 83,582 shares of company stock valued at $8,312,361.

Hedge Funds Weigh In On Billiontoone

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Perceptive Advisors LLC boosted its position in shares of Billiontoone by 26.1% in the first quarter. Perceptive Advisors LLC now owns 91,812 shares of the company’s stock valued at $7,248,000 after acquiring an additional 19,000 shares during the period. Bank of America Corp DE boosted its position in shares of Billiontoone by 8,603.4% in the first quarter. Bank of America Corp DE now owns 12,707 shares of the company’s stock valued at $1,003,000 after acquiring an additional 12,561 shares during the period. The Manufacturers Life Insurance Company boosted its position in shares of Billiontoone by 151.8% in the first quarter. The Manufacturers Life Insurance Company now owns 30,506 shares of the company’s stock valued at $2,408,000 after acquiring an additional 18,389 shares during the period. Renaissance Technologies LLC bought a new stake in shares of Billiontoone in the first quarter valued at approximately $4,046,000. Finally, Public Employees Retirement System of Ohio bought a new stake in shares of Billiontoone in the first quarter valued at approximately $1,539,000.

Billiontoone Trading Up 5.8%

NASDAQ:BLLN opened at $105.15 on Friday. The stock’s 50 day moving average price is $89.56 and its 200 day moving average price is $87.22. Billiontoone has a 52 week low of $61.96 and a 52 week high of $138.70. The company has a market capitalization of $4.84 billion and a P/E ratio of 191.18. The company has a debt-to-equity ratio of 0.18, a quick ratio of 10.58 and a current ratio of 10.92.

Billiontoone (NASDAQ:BLLN) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.34 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.33. The firm had revenue of $108.39 million during the quarter, compared to analyst estimates of $95.81 million. During the same quarter in the prior year, the company posted ($0.39) EPS. The company’s quarterly revenue was up 83.8% on a year-over-year basis. On average, research analysts forecast that Billiontoone will post 0.93 EPS for the current fiscal year.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.